• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by BIO-key International Inc.

    1/10/23 3:52:30 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology
    Get the next $BKYI alert in real time by email
    SC 13G 1 sc_13g.htm SCHEDULE 13G

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. ___)*

     

    BIO-KEY INTERNATIONAL, INC.

    (Name of Issuer)

     

    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

     

    09060C4087

    (CUSIP Number)

     

    December 22, 2022

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    [ ] Rule 13d-1(b)

     

    [X] Rule 13d-1(c)

     

    [ ] Rule 13d-1(d)

     

    * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     


     

    CUSIP No. 09060C4087

     

    1.

    Names of reporting persons.

     

    AJB Capital Investments LLC

    2.

    Check the appropriate box if a member of a group (see instructions)

     

    (a) [ ] (b) [ ]

    3. SEC use only
    4.

    Citizenship or place of organization

     

    United States

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person with:

    5.

    Sole voting power

     

    700,000 (1)

    6.

    Shared voting power

     

    0

    7.

    Sole dispositive power

     

    700,000 (1)

    8.

    Shared dispositive power

     

    0

    9.

    Aggregate amount beneficially owned by each reporting person

     

    700,000 (1)

    10.

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    [ ]

    11.

    Percent of class represented by amount in Item 9

     

    8.3% (2)

    12.

    Type of reporting person (see instructions)

     

    OO

     

    (1) Consists of 700,000 outstanding shares of common stock of the Issuer, par value 0.0001 (“Shares”), directly held by AJB Capital Investments LLC. AJB Capital Managers LLC is the manager of AJB Capital Investments LLC.
       
    (2) Based on 8,465,211 Shares outstanding as of November 11, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2022.

     

    - 2 -


     

    CUSIP No. 09060C4087

     

    1.

    Names of reporting persons.

     

    AJB Capital Managers LLC

    2.

    Check the appropriate box if a member of a group (see instructions)

     

    (a) [ ] (b) [ ]

    3. SEC use only
    4.

    Citizenship or place of organization

     

    United States

    Number of

    shares

    beneficially

    owned by

    each

    reporting

    person with:

    5.

    Sole voting power

     

    700,000 (1)

    6.

    Shared voting power

     

    0

    7.

    Sole dispositive power

     

    700,000 (1)

    8.

    Shared dispositive power

     

    0

    9.

    Aggregate amount beneficially owned by each reporting person

     

    700,000 (1)

    10.

    Check if the aggregate amount in Row (9) excludes certain shares (see instructions)

     

    [ ]

    11.

    Percent of class represented by amount in Item 9

     

    8.3% (2)

    12.

    Type of reporting person (see instructions)

     

    OO

     

    (1) Solely in its capacity as Manager of AJB Capital Investments LLC.
       
    (2) Based on 8,465,211 Shares outstanding as of November 11, 2022, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2022.

     

    - 3 -


     

    ITEM 1.

     

    (A) NAME OF ISSUER:

     

    Bio-Key International, Inc. (the “Issuer”)

     

    (B) ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICE:

     

    3349 Highway 138, Building A, Suite E
    Wall, NJ 07719

     

    ITEM 2.

     

    (A) NAME OF PERSONS FILING:

     

    AJB Capital Investments LLC and AJB Capital Managers LLC

     

    (B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

     

    4700 Sheridan Street, Suite J
    Hollywood, FL 33031

     

    (C) CITIZENSHIP:

     

    Florida, United States

     

    (D) TITLE OF CLASS OF SECURITIES:

     

    Common Stock, $0.0001 par value per share

     

    (E) CUSIP NUMBER:

     

    09060C4087

     

    ITEM 3. STATEMENT FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B) OR (C)

     

    Not applicable.

     

    ITEM 4. OWNERSHIP

     

    The information contained in Items 5-9 and 11 of the cover pages of this Schedule 13G is hereby incorporated by reference into this Item 4.

     

    AJB Capital Investments LLC (“AJB Investments”) is the direct owner of 700,000 shares of common stock of the Issuer, par value 0.0001 (“Shares”), constituting approximately 8.3% of the Issuer’s Shares, and has the sole power to vote and dispose of such securities.

     

    - 4 -


     

    AJB Capital Managers LLC (“AJB Managers”), in its capacity as the Manager of AJB Investments, has the ability to direct the management of the business of AJB Investments including the power to vote and dispose of securities beneficially owned by AJB Investments; therefore, AJB Managers may be deemed to have indirect beneficial ownership of the Shares held by AJB Investments.

     

    AJB Managers is managed by a board of managers (the “Board of Managers”) which operates by majority vote such that no individual member of the Board of Managers has voting or dispositive control over the Shares. Each individual constituting the Board of Managers therefore expressly disclaims beneficial ownership of these securities.

     

    Pursuant to Rule 13d-4 of the Exchange Act, the Reporting Persons declare that filing this Schedule 13G shall not be construed as an admission that any such person is, for the purposes of Section 13(d) and/or Section 13(g) of the Exchange Act, the beneficial owner of any securities covered by this Schedule 13G except to the extent of such person’s pecuniary interest in the Units, and except to the extent of its pecuniary interest, such beneficial ownership is expressly disclaimed by each Reporting Person.

     

    All calculations of percentage ownership herein are based on 8,465,211 Shares outstanding as of November 11, 2022, as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 14, 2022.

     

    ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

     

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ].

     

    ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

     

    Not applicable.

     

    ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON

     

    Not applicable.

     

    ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

     

    Not applicable.

     

    ITEM 9. NOTICE OF DISSOLUTION OF GROUP

     

    Not applicable.

     

    - 5 -


     

    ITEM 10. CERTIFICATION.

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of the undersigned’s knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Dated: January 10, 2023

     

    AJB CAPITAL INVESTMENTS LLC

     

    By:   AJB Capital Managers LLC, its Manager

    By:   /s/ Ari Blaine, Authorized Manager

     

    AJB CAPITAL MANAGERS LLC

     

    By:   /s/ Ari Blaine, Authorized Manager

     

     

    INDEX TO EXHIBITS

     

    Exhibit 99.1 Joint Filing Agreement

     

    - 6 -


    Get the next $BKYI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BKYI

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $BKYI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 102,775 units (SEC Form 4)

    4/A - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    9/17/25 5:19:52 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 112,174 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    9/17/25 10:47:40 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Welch Cecilia C was granted 35,000 shares, increasing direct ownership by 143% to 59,396 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    9/3/25 5:19:19 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    SEC Filings

    View All

    SEC Form 424B3 filed by BIO-key International Inc.

    424B3 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    12/2/25 4:49:23 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form EFFECT filed by BIO-key International Inc.

    EFFECT - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    12/2/25 12:15:32 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form S-1 filed by BIO-key International Inc.

    S-1 - BIO KEY INTERNATIONAL INC (0001019034) (Filer)

    11/21/25 5:04:41 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BIO-key Partners with SAVIS Group to Bring its Identity and Biometric Authentication Solutions to Vietnam

    HANOI, Vietnam and HOLMDEL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, today announced a strategic partnership with SAVIS Group, one of Vietnam's top information-technology enterprises, specializing in digital signing, identity verification, electronic authentication and cybersecurity services. Vietnam represents one of the most promising markets in Southeast Asia for digital transformation and cybersecurity innovation. The collaboration unites BIO-key's advanced IAM and biometric authentication platforms with SAVIS Group's nationwide experience in dig

    11/17/25 4:00:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Digital Identity and Biometric Access Management Provider BIO-key Reports Q3 Results; Highlights Enhanced Post Quarter Balance Sheet to Support 2026 Growth Goals; Holds Investor Call 10am ET Today

    HOLMDEL, N.J., Nov. 14, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, announced results for its third quarter (Q3'25) and nine months (9M'25) ended September 30, 2025. BIO-key is hosting an investor call today at 10:00am ET (details below). Recent Highlights Launched its next-generation EcoID III USB fingerprint scanner, delivering FBI FAP 20 certification, enhanced security, liveness detection and encrypted device-to-host communication.Partnered with IT2Trust, one of Scandinavia's most established IT security and networking solutions providers to increase its acc

    11/14/25 8:30:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Partners with VaporVM to Expand Reach of its Advanced Identity and Access Management and Biometric Cybersecurity Solutions in Middle East and Africa

    DUBAI, United Arab Emirates and HOLMDEL, N.J., Nov. 12, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, has executed a strategic partnership with VaporVM, a global leader in cloud, cybersecurity, and managed services headquartered in Dubai, U.A.E. This collaboration expands the potential for BIO-key to deliver its robust identity, authentication, and access management solutions to enterprises, public sector organizations, and institutions across the Middle East and Africa. The partnership combines VaporVM's cloud-native expertise, regional presence and customer base with

    11/12/25 4:00:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bio-key upgraded by Maxim Group with a new price target

    Maxim Group upgraded Bio-key from Hold to Buy and set a new price target of $6.00

    3/26/21 7:52:25 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 102,775 units (SEC Form 4)

    4/A - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    9/17/25 5:19:52 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Depasquale Michael W bought $3,233 worth of shares (4,117 units at $0.79), increasing direct ownership by 4% to 112,174 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    9/17/25 10:47:40 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    Chief Legal Officer Sullivan James David bought $7,700 worth of shares (10,000 units at $0.77), increasing direct ownership by 22% to 54,851 units (SEC Form 4)

    4 - BIO KEY INTERNATIONAL INC (0001019034) (Issuer)

    8/26/25 8:39:25 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Leadership Updates

    Live Leadership Updates

    View All

    BIO-key Partners with SAVIS Group to Bring its Identity and Biometric Authentication Solutions to Vietnam

    HANOI, Vietnam and HOLMDEL, N.J., Nov. 17, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a leading provider of Identity and Access Management (IAM) and biometric authentication solutions, today announced a strategic partnership with SAVIS Group, one of Vietnam's top information-technology enterprises, specializing in digital signing, identity verification, electronic authentication and cybersecurity services. Vietnam represents one of the most promising markets in Southeast Asia for digital transformation and cybersecurity innovation. The collaboration unites BIO-key's advanced IAM and biometric authentication platforms with SAVIS Group's nationwide experience in dig

    11/17/25 4:00:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Showcases Next-Generation Identity & Biometric Authentication Solutions at Premier Tech and Cybersecurity Events: GITEX 2025 in Dubai and 19ENISE in Spain

    DUBAI, United Arab Emirates and LÉON, Spain and HOLMDEL, N.J. , Oct. 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), a global leader in biometric-centric Identity and Access Management (IAM) solutions, is proud to announce its participation at two of the most influential cybersecurity and technology events of the year — GITEX Global 2025 in Dubai, U.A.E. and 19ENISE in León, Spain. At both events, BIO-key will demonstrate how its Identity-Bound Biometrics (IBB), PortalGuard® IAM, and Passkey:YOU™ solutions are empowering organisations across government, healthcare, and enterprise sectors to embrace a passwordless, phoneless, and tokenless future. Visitors will exp

    10/15/25 12:01:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Partners with Ping Identity to Bring its Cutting-Edge Biometric Authentication to Ping Customers

    DENVER and HOMDEL, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of Identity and Access Management (IAM) solutions including Identity-Bound Biometrics, and Ping Identity, a leading provider of seamless and secure digital experiences, announced today that BIO-key's unique biometric authentication technology is now included on the Ping Identity Integration Directory. The integration enables Ping clients to utilize BIO-key's powerful and seamless biometric authentication solution in combination with the PingOne Cloud Platform. The combined solution streamlines authentication processes and ensures a secure, frictionless user experien

    12/11/23 7:59:02 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Financials

    Live finance-specific insights

    View All

    Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET

    HOLMDEL, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, will host its third quarter investor call on Friday, November 14th at 10 a.m. ET. Results will be released before the market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session. Call DetailsDate / Time:Friday, November 14th at 10 a.m. ETCall Dial In #: 1-877-418-5460 U.S. or 1-412-717-9594 Int'lLive Webcast / Replay:Webcast & Replay Link – Available for 3 months.Audio Replay: 1-855-669-9658 U.S. or 1-412-317-0088 Int'l; code 48

    11/7/25 2:25:56 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key, Provider of Identity and Access Management Solutions with Enhanced Biometrics, Hosts Q2 Investor Call Wed. Aug. 13th at 10am ET

    HOLMDEL, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management solutions featuring passwordless, phoneless, and tokenless Identity-Bound Biometric authentication, will host its second quarter 2025 investor call on Wednesday, August 13th at 10 a.m. ET. Results will be released before the stock market opens that morning. Mike DePasquale, Chairman & CEO and Cecilia Welch, CFO will lead the conference call and host a Q&A session. Call Details Date / Time:Call Dial In #:Live Webcast / Replay:Audio Replay:Wednesday, August 13th at 10 a.m. ET1-877-418-5460 U.S. or 1-412-717-9594 Int'lWebca

    8/5/25 7:59:00 AM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    BIO-key Reports Q1'25 Revenue of $1.6M and Improved Cash Position of $3.1M; Hosts Investor Call Tomorrow, Friday May 16th at 10am ET

    HOLMDEL, N.J., May 15, 2025 (GLOBE NEWSWIRE) -- BIO-key® International, Inc. (NASDAQ:BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and tokenless Identity-Bound Biometric (IBB) authentication, announced results for its first quarter (Q1'25). BIO-key will host an investor call tomorrow, Friday, May 16th at 10:00am ET (details below). BIO-key CEO, Mike DePasquale commented, "Our revenue rose approximately 10% sequentially vs. Q4'24, as we continue our transition to selling high-margin BIO-key branded products in Europe, the Middle East and Africa (EMEA). Year-over-year revenue decreased 25% due to a

    5/15/25 4:15:00 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    $BKYI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by BIO-key International Inc.

    SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    11/14/24 5:05:04 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G filed by BIO-key International Inc.

    SC 13G - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    2/14/24 3:30:35 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by BIO-key International Inc. (Amendment)

    SC 13G/A - BIO KEY INTERNATIONAL INC (0001019034) (Subject)

    2/13/24 8:04:15 PM ET
    $BKYI
    Computer Software: Prepackaged Software
    Technology